PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

NEW ORLEANS — Use of spirometry with bronchodilator testing can help reduce overdiagnosis of COPD as well as help differentiate COPD from asthma and asthma-COPD overlap syndrome, researchers ...

Notably, the likelihood for bronchodilator responsiveness per the 2005 definition significantly went down with testing in autumn vs. winter (aOR = 0.67; 95% CI, 0.48-0.92), according to the study.

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease. J Thorac Dis. 2021;13 (2): 511-520. doi: 10.21037/jtd-20-985 ...

New use of long-term inhaled bronchodilators is associated with an early increase in the risk for cardiovascular disease (CVD), the findings of a new study suggest. In a large observational study ...

Each patient's bronchodilator responsiveness (BDR) was determined by three measures: absolute change in the volume of air exhaled during a forced breath in one second (FEV1) (BDRABS); change as ...

Cite this: Unpredictability of Deception in Compliance With Physician-Prescribed Bronchodilator Inhaler Use in a Clinical Trial - Medscape - Aug 01, 2000.

First, it is a bronchodilator, opening airways in the lungs to make breathing easier. Second, it is anti-inflammatory, reducing COPD exacerbations or flare-ups, a sudden worsening of symptoms.

HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March 11 in Thorax. Ben Knox ...